We are live on ! Find out more
ALM

Almonty Industries

Positive
Neutral
Negative
Sentiment 3-Months
Positive 23.1%
Neutral 73.1%
Negative 3.8%

Positive
Zacks Investment Research
5 days ago
Almonty Industries Inc. (ALM) Stock Jumps 13.6%: Will It Continue to Soar?
Almonty Industries Inc. (ALM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Almonty Industries Inc. (ALM) Stock Jumps 13.6%: Will It Continue to Soar?
Negative
Zacks Investment Research
10 days ago
Are Basic Materials Stocks Lagging Almonty Industries Inc. (ALM) This Year?
Here is how Almonty Industries Inc. (ALM) and Element Solutions (ESI) have performed compared to their sector so far this year.
Are Basic Materials Stocks Lagging Almonty Industries Inc. (ALM) This Year?
Neutral
Business Wire
16 days ago
Almonty to Voluntarily Delist From ASX
DILLON, Mont.--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company“) (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1) announces that the Company has requested and received formal approval from the Australian Securities Exchange (“ASX”) to be removed from the official list of ASX pursuant to ASX Listing Rule 17.11 (“Delisting”), subject to the conditions described below. This follows the Company's decision to delist the common shares of the Company (“Shares”) from the Toront.
Almonty to Voluntarily Delist From ASX
Neutral
Business Wire
20 days ago
Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older
BARCELONA, Spain--(BUSINESS WIRE)--Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, today announced that the European Medicines Agency (EMA) has accepted the submission of the extension of the Marketing Authorisation Application (MAA) of Ebglyss® (lebrikizumab) for the treatment of children and adolescents aged 6 months to
Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older
Neutral
Business Wire
22 days ago
Almonty to Voluntarily Delist From TSX
DILLON, Mont.--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company”) (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, today announced that it will voluntarily delist the common shares of the Company (the “Common Shares”) from the Toronto Stock Exchange (the “TSX”) effective as of the close of trading on July 31, 2026 (the “Delisting”). Following such date, the Common Shares will no longer be traded on the TSX, but will con.
Almonty to Voluntarily Delist From TSX
Neutral
GlobeNewsWire
24 days ago
Diamond Equity Research Releases Update Note on Almonty Industries, Inc. (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1)
New York, July 16, 2026 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an Update Note on Almonty Industries, Inc. (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1).  The research summary below is from an issuer-sponsored report commissioned by Almonty Industries, Inc. and produced by Diamond Equity Research. The update note includes detailed information on the Almonty Industries' business model, services, industry overview, financials, valuation, management profile, and risks.
Diamond Equity Research Releases Update Note on Almonty Industries, Inc. (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1)
Positive
Zacks Investment Research
26 days ago
All You Need to Know About Almonty Industries Inc. (ALM) Rating Upgrade to Buy
Almonty Industries Inc. (ALM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
All You Need to Know About Almonty Industries Inc. (ALM) Rating Upgrade to Buy
Positive
Zacks Investment Research
26 days ago
Is Almonty Industries Inc. (ALM) Stock Outpacing Its Basic Materials Peers This Year?
Here is how Almonty Industries Inc. (ALM) and Kronos Worldwide (KRO) have performed compared to their sector so far this year.
Is Almonty Industries Inc. (ALM) Stock Outpacing Its Basic Materials Peers This Year?
Neutral
Business Wire
26 days ago
Almonty Expands Sangdong Tungsten Offtake Agreement with Global Tungsten & Powders to US$490 Million in Contracted Annual Revenue at Current APT Pricing
DILLON, Mont.--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company”) (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, today announced that it has entered into an amendment (the “Amendment”) to its long-term offtake agreement (the “Agreement”) with Global Tungsten & Powders LLC (“GTP”), a member of Austria's Plansee Group, covering tungsten concentrate produced from Phase I of the Company's Sangdong Mine in South Korea.
Almonty Expands Sangdong Tungsten Offtake Agreement with Global Tungsten & Powders to US$490 Million in Contracted Annual Revenue at Current APT Pricing
Neutral
Business Wire
1 month ago
Almonty Commences Processing Operations at Sangdong Mine, Marking Transition to Saleable Tungsten Concentrate Production
DILLON, Mont.--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company”) (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, today announced the commencement of processing plant throughput operations at its Sangdong Mine in Gangwon Province, South Korea. During June 2026, the Company began feeding stockpiled run-of-mine ore through its newly commissioned processing plant to produce saleable tungsten concentrate — a pivotal milest.
Almonty Commences Processing Operations at Sangdong Mine, Marking Transition to Saleable Tungsten Concentrate Production